Groww Logo
Home>US Stocks>Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

Healthcare
$645.52
+ $11.56 (1.82%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $635.38$633.96604,565660,685

      Fundamentals

      Market Cap$70.90B
      P/B Ratio3.6
      P/E Ratio8.9
      Enterprise Value$70.26B
      Div. Yield0.00%
      Book Value186.47
      EPS(TTM)9.12
      ROENA
      Understand Fundamentals

      About the Company

      An American biotechnology company, Regeneron Pharmaceuticals has its headquarters in Westchester County, New York. The place is located around 25 miles north of Midtown Manhattan. Founded in 1988, the company is mostly focused on neurotrophic factors
      An American biotechnology company, Regeneron Pharmaceuticals has its headquarters in Westchester County, New York. The place is located around 25 miles north of Midtown Manhattan. Founded in 1988, the company is mostly focused on neurotrophic factors and regenerative capabilities associated with them, leading to the adoption of this company's name. The company has developed various products including a VEGF inhibitor, aflibercept, an interleukin-1 blocker and rilonacept. Bloomberg would go on to announce that Sanofi and Regeneron were developing a new drug by March 2012. This drug would help reduce cholesterol up to 72% more than many of its competitors. The company also produces different kinds of drugs, such as Arcalyst meant for specific, rare autoinflammatory conditions. It was approved by the FDA in 2008. Eylea, used to treat common causes of blindness in the elderly, was approved by the FDA in November 2011. Zaltrap, another drug by the company, is for metastatic colorectal cancer and was approved by the FDA in August 2012. The company also produced other drugs like Praluent for clinical atherosclerotic cardiovascular disease, requiring additional lowering of low-density lipoprotein (LDL) cholesterol. Dupixent is a drug developed by this company to treat adolescent and adult atopic dermatitis. Kevzara, another notable product of this company, is a solution for subcutaneous injection and ZALTRAP injection for Intravenous Infusion. It has nearly 16 products that are in the process of clinical development. This company ranked at 151 in the World's Best Employers list 2020 and 62 in Just Companies' list in 2021. It also ranked at 646 in the Global 2000 list 2020 and 275 in Best Employers for Diversity list in 2020. This company also ranked at 61 in the list of America's Best Midsize Employers in 2019 and at 145 in the Best Employers for Women in 2018. It has a workforce of 8100 employees and has offices in three countries, including the United States, Ireland and the United Kingdom. The company got the 16th rank in the list of World's Most Innovative Companies in 2018. Regeneron Pharmaceuticals shares trade on the NASDAQ stock exchange under the ticker symbol "REGN."
      ...Read more
      OrganisationRegeneron Pharmaceuticals, Inc.
      IndustryBiotechnology
      HeadQuartersTarrytown, NY

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Regeneron Pharmaceuticals, Inc.

      Can I Buy Regeneron Pharmaceuticals, Inc. Shares in India?

      Yes, Regeneron Pharmaceuticals, Inc. shares can be bought in India by opening an international trading account with Groww.

      How to Buy Regeneron Pharmaceuticals, Inc. Shares in India?

      One can easily invest in Regeneron Pharmaceuticals, Inc. shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Regeneron Pharmaceuticals, Inc. shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Regeneron Pharmaceuticals, Inc..

      What is the Share Price of Regeneron Pharmaceuticals, Inc.?

      The share price of Regeneron Pharmaceuticals, Inc. is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Regeneron Pharmaceuticals, Inc. share price is $645.52 as of 15 May ‘22

      What is the Market Cap of Regeneron Pharmaceuticals, Inc.?

      The Regeneron Pharmaceuticals, Inc. market cap is $70.90B as of 15 May ‘22

      What is the PE and PB ratio of Regeneron Pharmaceuticals, Inc.?

      The PE and PB ratio of Regeneron Pharmaceuticals, Inc. is 8.9 and 3.6 as of 15 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.7
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW